We have used a non-transformed cell model, the primary cultured hepatocyte, to explore the turnover ofinositol hexakisphosphate, multiple isomers of inositol pentakisphosphate and two novel diphosphoinositol polyphosphates. All of these compounds gradually accumulated radioactivity throughout a 70 h period of labelling with [3H]inositol. However, a rapid metabolic rate was revealed upon inhibition of diphosphoinositol polyphosphate biphosphatase(s) with 1 mM fluoride for 40 min: this treatment elevated levels of [3H]diphosphoinositol polyphosphates up to 10-fold, indicating that their cellular pools were normally turning over at least 10 times every 40 min. This was accompanied by a turnover of about 10 % of the pool of inositol hexakisphosphate.
INTRODUCTION
Ins(1,4,5)P1 and Ins(1,3,4,5)P4 have provided the primary focus for studies into the importance of inositol phosphate metabolism to mammalian cell physiology. This interest stems from Ins(1,4,5)P3 being a Ca2l-mobilizing signal, the levels of which increase several-fold upon receptor activation, due to an accelerated breakdown of PtdIns(4,5)P2 (reviewed by Berridge and Irvine, 1989) . The 3-kinase-mediated phosphorylation of Ins(1,4,5)P3 forms Ins(1,3,4,5)P4 (reviewed by Shears, 1992) ; there are several reports that Ins(1,3,4,5)P4 augments Ca2+ signalling (reviewed by Irvine, 1992) , although there is some controversy concerning how widespread this role of Ins(1,3,4,5)P4 might be (Bird et al., 1991) . A well characterized series of enzymes dephosphorylate both Ins(1,4,5)P3 and Ins (1,3,4,5)P4 to inositol (see Shears, 1992) , which can then be reutilized for resynthesis of the inositol lipids.
Much less attention has been given to InsP5 and InsP6, yet these metabolites comprise the bulk of the inositol polyphosphate content in mammalian cells. This comparative neglect in part reflects the difficulties involved in the study of these higher polyphosphates, but in addition they have often been considered to be unlikely to contribute to the short-term regulation of cell function (see Berridge and Irvine, 1989 Ins(1,3,4,5,6)P, is not the only InsPs isomer (Guse and Emmrich, 1991; McConnell et al., 1991; Stephens et al., 1991; Wong et al., 1992) ; (2) evidence that agonists stimulate Ins(1,3,4,5,6)P, dephosphorylation to Ins(3,4,5,6)P4 (Menniti et al., 1990 (Menniti et al., , 1993b ; (3) the discovery that Ins(1,3,4,5,6)PJ and InsP6 can be converted into diphosphate derivatives, both in the AR4-2J pancreatoma cell line and in the slime mould Dictyostelium discoideum (Menniti et al., 1993a; Stephens et al., 1993) ; (4) the purification of an enzyme that dephosphorylates InsPF to a number of InsP5 isomers (Nogimori et al., 1991) , several of which can be phosphorylated back to InsPJ in cell-free systems Stanley et al., 1992) . There are no known functions for this baffling array of potential InsPJ/InsP. substrate cycles, but evidence for their association with cell signalling was recently suggested by a study with Jurkat T-lymphocytes. In the latter cells, levels of several InsP. isomers were regulated by occupation of phospholipase Clinked receptors, in part at least by Ca2+-dependent mechanisms (Guse and Emmrich, 1991 Abbreviations used: DMSO, dimethyl sulphoxide. Inositol phosphates are abbreviated according to IUPAC nomenclature. Some inositol phosphate isomers have naturally occurring enantiomers; where these enantiomeric pairs were not individually resolved, the D/L prefix is used, i.e. D/L-lns(1,2,4,5,6)P5=D-lns(1,2,4,5,6)P5+L-lns(1,2,4,5,6)P5 [the latter may also be written as D-lns(2,3,4,5,6 )P5]. Two diphosphate derivatives of Ins (1, 3, 4, 5, 6 )P5 and InsP6 are denoted as PP-lnsP4 and PP-lnsP5; we have previously used the terms 'IP5P' and 'IP6P' respectively (Menniti et al., 1993a) , but the newer abbreviations are both consistent with the format used by other workers (Stephens et al., 1993) and conform with IUPAC recommendations. We propose that there is only a single diphosphate group in each of our derivatives (the text provides data that are consistent with this assumption). (Menniti et al., 1990) . These cells were also the source of the 3H-labelled diphosphate derivatives of Ins(1, 3, 4, 5, 6)P5 and InsP,, which accumulate to high levels after 1 h of treatment of the cells with 10 mM NaF (Menniti et al., 1993a) . D/L-[3H]Ins(1,2,4,5,6)PJ was isolated from an extract of [3H]inositollabelled T5-1 cells, using a Partisphere SAX column (McConnell et al., 1991) . All of these preparations were desalted with triethylamine bicarbonate (Menniti et al., 1993a (Menniti et al., 1990) . The plates were washed twice with 2 ml of ice-cold 6% (v/v) perchloric acid, and then the 3H-labelled inositol lipids were dissolved overnight in 2 ml of 0.1 M NaOH containing 0.1 0% (v/v) Triton X-100; 50 ,1 aliquots were counted for radioactivity.
MATERIALS AND METHODS
Inositol phosphates in the neutralized extracts were separated by h.p.l.c. using one of two methods. One utilized an Adsorbosphere SAX column eluted at 1 ml/min with water for 10 min, followed by a 2 h linear gradient generated by mixing water with 0-80% 1 M NH4H2PO4, pH 3.35 (Balla et al., 1989; Menniti et al., 1990) . Alternatively, inositol phosphates were separated on a Partisphere 5,u SAX column which was eluted at 1 ml/min with a gradient generated by mixing water (buffer A) with 1.15 M (NH4)2HP04, pH 3.8 (buffer B), by a slight modification of the method described by Stephens (1990) In most of those animal cell types that have been studied to date, almost all of the InsP, is the 1,3,4,5,6-isomer (Johnson and Tate, 1969; Mayr, 1988; Phillippy and Bland, 1988; Menniti et al., 1990; Mattingly et al., 1991; Stephens et al., 1991; . Likewise, in hepatocytes nearly 98 % of total [3H]InsPJ was [3H]Ins(1,3,4,5,6)PJ (peaks I and N, Figure 1 ). Nevertheless, additional specific InsPJ isomers were assigned to some further peaks (G, H, 0 and P in Figure 1 ) with the aid of some standards plus the known elution properties of two h.p.l.c. systems (for by an enzyme with limited capacity; a phosphatase with just these characteristics has been purified from rat liver (Nogimori et al., 1991) . Balla et al. (1989) and Menniti et al. (1990) . The elution characteristics of InsP5 isomers on an Adsorbosphere SAX h.p.l.c. column were previously determined by Nogimori et al. (1991) , who chromatographed a mixture of InsP5s, collected the individual peaks, and rechromatographed each of them on a Dionex AS7 column (Phillippy and Bland, 1988; McConnell et al., 1991) , which in turn was calibrated with genuine [3H]lnsP5 standards . An arrow marks the elution position of PP-lnsP4 on the Adsorbosphere column, which was determined in a sequentially performed h.p.l.c. run. The inset to (a) shows data from a different sample, with slightly improved resolution of Ins(1,3,4)P3 (A; 1347), Ins(1,4,5)P3 (B; 1914) and an unknown peak (C; 709). In (b) (the Partisphere SAX column), isomers were identified as follows (the d.p.m. for each isomer follows it in parentheses). PP-lnsP4 (Q; 527), InsP6 (R; 212703) and PP-lnsP5 (S; 2593) were each identified from their co-elution with genuine standards (see the Materials and methods section for sources). The elution of lns(1,3,4,5,6)P5 (peak N) was also determined with a standard, and this peak (total = 265551 d.p.m.) includes a contribution from D/L-lns(1,2,3,4,5)P5 (peak 0) (see Stephens, 1990) . The elution of D/L-lns(1,2,4,5,6)P5, again confirmed with a standard, includes lns(1,2,3,4,6)P5 (P; total d.p.m. = 4949) (Stephens, 1990 6. (1993) also showed that during their h.p.l.c. procedure, which we have copied here (Figure lb) , the first of their compounds to elute after InsP6 was PP-InsPJ , followed by bis-PP-InsP4. It is therefore possible that the material in peaks K and S (Figure 1 ) is also a PP-InsPJ?, and conceivably it is even D-and/or L-I-PP-InsPJ . As we have no independent information concerning the position of the diphosphate group in our compound, we shall use PP-InsPJ as generic and somewhat putative terminology to describe peaks K and S. Note that in our earlier publication we referred to this compound as 'IP6P' (Menniti et al., 1993a) . The later-eluting 'IP6X' (Menniti et al., 1993a ), which we have not observed in hepatocytes (Figure 1 ), could be similar to bis-PP-InsP4, but further work is necessary to investigate this possibility. Figure 1 ). PP-InsP4 was not observed on the Adsorbosphere SAX column, because of its small size and its elution close to the much larger peak of InsP6 (Figure 1 ). Our use of standards to identify the diphosphoinositol polyphosphates was supplemented by demonstrating specific increases in the levels of these particular compounds in response to fluoride (see below).
Rate of incorporation of [3H]Inositol into InsP5, mnsP6, PP-InsP4 and PP-InsP5
In these experiments, the radioactivity in the inositol lipids attained an apparent steady-state within 24 h (results not shown). In contrast, radioactivity accumulated much more slowly into a number of highly polar inositol polyphosphates (Figure 2 ). Despite some differences in the individual rates of labelling, there were near-constant values for the ratios of both PP-InsP4/InsP5
and PP-InsP5/InsP6 (inset to Figure 2c ). These data imply that there is a close metabolic relationship between InsP5 and PPInsP4, and between InsP6 and PP-InsP5. This is consistent with earlier evidence, obtained from AR4-2J cells, indicating that Ins(1,3,4,5,6)P5 and InsP6 are respectively the precursors of PP-InsP4 and PP-InsP5 (Menniti et al., 1993a) .
Between 62 and 70 h of labelling with [3H]inositol (Figure 2 ), there was no significant change in the levels of radioactivity in the following compounds: InsP6, PP-InsP5, PP-InsP4, Ins(1,3,4,5,6)P5, D/L-Ins(1,2,3,4,5)P5 and the peak (denoted P in Figure 1 ) that contained a mixture of D/L-Ins(1,2,4,5,6)P5 plus Ins(1,2,3,4,6)P5. When we determined the effects of extracellular agents upon these polyphosphates (see below), we routinely labelled hepatocytes for 62 h. Within the time-frame of these experiments (e.g. 30 min in Figure 3) slowly, and less dramatically (2-fold above basal). These latter effects are again similar to the response seen in freshly isolated hepatocytes (Hansen et al., 1988) . The data in Figures 1 and 3 demonstrate that the primary cultured hepatocytes have been maintained for a sufficient time to adequately label InsP. and InsP6, while also retaining the ability of vasopressin to activate phospholipase C in a manner that quantitatively and qualitatively mimics that seen in freshly isolated cells. Thus we were able to utilize the hepatocyte to investigate the relationship between phospholipase C activity and the turnover of some of the highly polar inositol phosphates. For example, we have now shown (Figure 3 ) that hepatocytes are similar to a number of cell types (Stephens et al., 1988; Balla et al., 1989; Menniti et al., 1990; Guse and Emmrich 1991; Barker et al., 1992) in that receptor-dependent activation of phospholipase C is accompanied by a parallel increase in levels of D/L-[3H]Ins(3,4,5,6)P4. Our data do not provide any new information on the source of D/L-Ins(3,4,5,6)P4, which we have previously proposed is Ins(1,3,4,5,6)P5 (Menniti et al., 1990 (Menniti et al., , 1993b Oliver et al., 1992) . Although vasopressin doubled the size of the D/L-[3H]Ins(3,4,5,6)P4 peak in hepatocytes, this could have been supported by only a 4 % increase in the turnover of the substantially larger peak of [3H]Ins(1,3,4,5,6)PJ; such a small change could not be detected in our experiments. Guse and Emmrich (1991) have shown that, as in hepatocytes (Figures 1 and 2) , the Jurkat lymphocyte cell line contains low levels of Ins(1,2,3,4,6)P1 in relation to total InsPJ. In the Jurkat cells, levels of this Ins(1,2,3,4,6)PJ increased 4-fold in response to activation of phospholipase C. This was accompanied by a persistent decrease of up to 35 % in levels of D/L-Ins(1,2,4,5,6)P5. The latter response was attributed to a Ca2l-dependent activation of a D/L-Ins(1,2,4,5,6)PI kinase (Guse and Emmrich, 1991) . In hepatocytes, treatment of up to 30 min with vasopressin (or 40 min of treatment with thapsigargin, see below) did not alter the sizes of the Ins(1,2,3,4,6)P5 peak (denoted G in Figure 1) , the D/L-Ins(l,2,3,4,5)P, peak (denoted H in Figure 1 Ins(1,2,4,5,6)PJ were similar to those of Ins(1,3,4,5,6)P, (Guse and Emmrich, 1991 (Figure 3 ). In nine experiments (including that in Figure 3) (Jackson et al., 1988 (Menniti et al., 1993a Figure 2 ). One earlier study of the turnover of diphosphoinositol polyphosphates in intact cells (the AR4-2J pancreatoma) also indicated a quite rapid ongoing flux through these novel metabolites (Menniti et al., 1993a Figure 4) .
In three separate preparations of hepatocytes incubated with fluoride (including that described by Figure 4) 
General conclusions
There is an enormous body of literature describing the turnover of Ins(1,4,5)P3 and its closely related metabolites (Berridge and Irvine, 1989; Shears, 1992) . A large majority of these studies have been restricted to the analysis of inositol derivatives with four phosphates or less. While a number of reports describe the presence in cells of InsP6 and InsP5 (often assumed to be solely the 1,3,4,5,6-isomer), there has not been any general focus upon these particular compounds, and most of the relevant knowledge we do possess has been obtained from studies with either cell-free systems or transformed cell lines (see the Introduction). It has been the intention of this study to specifically pursue these relatively neglected areas of inositol phosphate metabolism, using a non-transformed cell, the primary cultured hepatocyte. We have now shown that this cell type contains a complex array of highly polar inositol derivatives. For example, although the bulk of the InsP5 complement in cells is composed of Ins(1, 3, 4, 5, 6 )P5, we have detected at least three additional InsP5 isomers. The levels of these additional InsJ% isomers, in relation to InsP6, are consistent with their being formed by the lowcapacity, non-specific InsP, phosphatase that has been purified from rat liver (Nogimori et al., 1991) . In order to study the physiological significance of these multiple InsP5 isomers, it might be best to concentrate future research efforts on specific cell types in which their levels respond to receptor occupation (Guse and Emmrich, 1991) .
We have also found that hepatocytes contain two diphosphoinositol polyphosphates that display a rapid ongoing metabolic turnover. Steady-state levels of these compounds were unaffected by activation of phospholipase C, but were reduced by prolonged elevation of cytosolic [Ca2+] (although it is possible that this effect is also due to the concomitant drop in intraluminal Ca2+). Vasopressin may not imitate the effect of thapsigargin upon the turnover of PP-InsP4 and PP-InsP5 because the agonist elevates intracellular [Ca2+] in a less sustained manner (e.g. see Rooney et al., 1991) . Sustained high levels of cytosolic Ca2 , such as those induced by xenobiotics for example, are ultimately toxic to the cell; hepatocytes have protective processes that act to both tolerate and reverse these potentially lethal changes (Nagelkerke et al., 1989) . It is conceivable that, in response to these more dramatic increases in cytosolic [Ca2+] , alterations in metabolic fluxes through diphosphoinositol polyphosphates represent an event of functional significance.
